Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fillet

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Revue Medicale De Liege|January 21, 2010
[Proteomics studies on arthritis by SELDI-TOF-MS: identification of the S100 proteins family as proteins of interest]D De Seny, C Ribbens, G Cobraiville, et al.
Journal of Chromatography. A|September 8, 2009
Critical analysis of several analytical method validation strategies in the framework of the fit for purpose conceptA Bouabidi, E Rozet, M Fillet, et al.
Bioorganic & Medicinal Chemistry|September 11, 1999
Preparation and pharmacological evaluation of the R- and S-enantiomers of 3-(2-butylamino)-4H- and 3-(3-methyl-2-butylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxide, two tissue selective ATP-sensitive potassium channel openersS Khelili, P de Tullio, P Lebrun, et al.
AIDS (London, England)|April 26, 2000
Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patientsB M Anduze-Faris, A M Fillet, J Gozlan, et al.
AIDS (London, England)|February 24, 2001
Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapyM Jouan, M Savès, R Tubiana, et al.
AIDS (London, England)|June 15, 2000
Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapyD Salmon-Céron, M C Mazeron, S Chaput, et al.
Journal of Medical Virology|June 29, 2004
Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infectionS Alain, S Hantz, C Scieux, et al.
Vox Sanguinis|August 27, 2016
International Forum regarding practices related to donor haemoglobin and ironM Goldman, K Magnussen, J Gorlin, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Revue Medicale De Liege|January 21, 2010
[Proteomics studies on arthritis by SELDI-TOF-MS: identification of the S100 proteins family as proteins of interest]D De Seny, C Ribbens, G Cobraiville, et al.
Journal of Chromatography. A|September 8, 2009
Critical analysis of several analytical method validation strategies in the framework of the fit for purpose conceptA Bouabidi, E Rozet, M Fillet, et al.
Bioorganic & Medicinal Chemistry|September 11, 1999
Preparation and pharmacological evaluation of the R- and S-enantiomers of 3-(2-butylamino)-4H- and 3-(3-methyl-2-butylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxide, two tissue selective ATP-sensitive potassium channel openersS Khelili, P de Tullio, P Lebrun, et al.
AIDS (London, England)|April 26, 2000
Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patientsB M Anduze-Faris, A M Fillet, J Gozlan, et al.
AIDS (London, England)|February 24, 2001
Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapyM Jouan, M Savès, R Tubiana, et al.
AIDS (London, England)|June 15, 2000
Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapyD Salmon-Céron, M C Mazeron, S Chaput, et al.
Journal of Medical Virology|June 29, 2004
Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infectionS Alain, S Hantz, C Scieux, et al.
Vox Sanguinis|August 27, 2016
International Forum regarding practices related to donor haemoglobin and ironM Goldman, K Magnussen, J Gorlin, et al.
Pageof 10